Exner, M <br/><br/>
The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.  [electronic resource] 

 -  FEBS letters  Mar 2000 
 - 47-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-5793 
<br/><br/><label>Standard No.: </label>10.1016/s0014-5793(00)01289-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arteriosclerosis--prevention & control<br/>Aspirin--metabolism<br/>Cells, Cultured<br/>Diabetic Angiopathies--prevention & control<br/>Endothelium, Vascular--drug effects<br/>Gentisates<br/>Glucose--metabolism<br/>Humans<br/>Hydroxybenzoates--metabolism<br/>Iron Chelating Agents--metabolism<br/>Lipoproteins, LDL--metabolism<br/>Male<br/>Oxidation-Reduction<br/>Prodrugs--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Salicylic Acid--metabolism<br/>Thromboplastin--biosynthesis